Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes
about
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individualsHistopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.BACH1 Ser919Pro variant and breast cancer risk.No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing geneATM variants and cancer risk in breast cancer patients from Southern Finland.Origin and distribution of the BRCA2-8765delAG mutation in breast cancerComprehensive analysis of NuMA variation in breast cancer.Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer familiesA role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian populationMulti-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.Hereditary breast cancer and handling of patients at risk.Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer familiesTargeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.Mutation analysis of the CHK2 gene in families with hereditary breast cancer.Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer familiesFANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.Analysis of autism susceptibility gene loci on chromosomes 1p, 4p, 6q, 7q, 13q, 15q, 16p, 17q, 19q and 22q in Finnish multiplex families.Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995.Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.BARD1 variants Cys557Ser and Val507Met in breast cancer predispositionGenome-wide scanning for linkage in Finnish breast cancer familiesNQO1 expression correlates inversely with NFκB activation in human breast cancerGlycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patientsNo germline FH mutations in familial breast cancer patients
P2860
Q22000758-6A0E58A5-7E34-48B4-821A-51FC852D56EAQ24796660-87E10194-06DB-4D04-BFF1-878C10F44CC5Q24810584-B0E4C353-E8BE-494A-8E38-E61EC68694D4Q25257890-EF7D634A-B5FE-4941-A889-C46EEF706410Q28211127-278200F5-92A7-42F3-B559-2D9836C0FC1BQ28242019-C0556B3F-0104-49B6-924A-24975F1131BCQ33254230-2431C9C3-6FD1-40AC-8F79-5B398E65E148Q33291268-C50A9D66-C855-4F6B-99BF-1F61D8D8F55AQ33323243-65D9F248-F136-402E-B8A6-F5432C690B87Q33337514-8C89C2A4-B51C-420F-A83E-A5D8B2A37A77Q33484437-4AC76554-0C54-4F2F-A6EE-DEA9C29326FFQ33628755-9F44E57A-4F39-4AAE-90A7-747B2287747EQ33792732-213E7759-C672-4886-9FF1-92E87324FB3DQ33933643-1F6FAC86-D453-4A21-8769-690F831DE98BQ34964524-858EC672-B651-4429-9B21-B94961E50CC8Q35008189-99B841B4-8F6F-4439-B1A4-25B959117839Q35209967-092F58B9-5D21-4EF5-A03D-0DE0BD67569EQ35502165-30F63060-6E77-41F3-B7EB-3DDD0E4D94B9Q35906993-940CED81-B9FC-41CB-B918-1ED9C4B80D1AQ36623420-68B16FED-A14B-4526-B21F-048C7DF2490EQ36643102-58AEBF59-713E-4B1C-9243-4A600CE939C6Q37394076-3BE26580-7980-4C59-912C-1DBC60E0D770Q38492869-18FA371B-A2FF-40A1-B519-93EAAE10903EQ41111172-A4E3E989-DD74-4058-871E-789ADB05A7D7Q42683589-6FE45E14-E366-4A0C-A2B3-392DA0C66123Q45326488-31949D5E-932D-4624-B07F-CFC88246184DQ46914764-E4BF5840-160F-432E-849D-FEF7F17F987AQ47121298-16EAD8CC-F0CE-41E1-9419-9B886D67721FQ47983920-8E9338A1-17E1-4CB5-A060-D892D625E73CQ48085053-E50C81F3-9099-4A80-A6F1-69AD2D1C5241Q50312757-D899F67E-854F-4239-BE89-86BA4E341728Q52132251-C0F52526-29B1-408C-98D4-80E146182DDAQ54279806-46C4A1CF-1C7C-40A3-A409-9DA23D4C0120Q57274795-43853BCC-22EA-4841-AA7B-AFFE5B639769Q57274804-5FBAB180-A864-43BC-8184-6DBFA01FE466Q57306207-64F0568B-62A2-4F81-AE85-3A4410306BB7Q57306210-6641B13A-D8CF-46A6-8EF9-3E0E15514A6BQ57306224-DE666491-96DE-43BC-955D-5C73B03A9849
P2860
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes
description
article
@en
im Dezember 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1997
@uk
name
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@en
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@nl
type
label
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@en
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@nl
prefLabel
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@en
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@nl
P2093
P356
P1476
Low proportion of BRCA1 and BR ...... dditional susceptibility genes
@en
P2093
K Syrjäkoski
L S Friedman
L Sarantaus
P Vehmanen
S Pyrhönen
P304
P356
10.1093/HMG/6.13.2309
P577
1997-12-01T00:00:00Z